Natalie Cole has more than 17 years of experience in neuroscience focusing on neurological disorders. She brings to GBHI research experience in amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease (AD), as well as experience in developing potential treatment therapies for various neurodegenerative diseases.
Before joining Trinity College Dublin, Cole was an assistant professor of neurology at Northwestern University and was part of the research team that discovered the gene encoding the protein alsin, ALS2, is mutated in a form of recessive ALS. She returned to Ireland as a research fellow at Trinity with an interest in the preclinical evaluation of therapeutic compounds for neurological diseases, including AD. Cole subsequently worked as project manager of Mercers Institute for Successful Ageing. She is now the project manager of DemPath, a project funded by the Genio Trust to develop an integrated care pathway for people with dementia in St. James’s Hospital, Dublin.
Bio: Natalie Cole is the research and development project manager for DemPath, an integrated care pathway for people with dementia in St. James’s Hospital, Dublin. She earned her doctorate degree in industrial microbiology from University College Dublin.